CD8+ as a Predictive Factor for Response to Anthracycline-Based Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer at Dr. Soetomo General Hospital, Surabaya, January 2024-August 2025. Vascular and Endovascular Review, [S. l.], v. 8, n. 13s, p. 155–161, 2025. DOI: 10.64149/. Disponível em: https://verjournal.com/index.php/ver/article/view/1000. Acesso em: 28 jun. 2026.